Dr. Maria Werner-Wasik, MD

Dr. Werner-Wasik practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Werner-Wasik's NPI, 1467476713, was assigned on July 27, 2006. Dr. Werner-Wasik holds Pennsylvania license MD-049673-L.

Dr. Werner-Wasik's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Werner-Wasik's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Jefferson University Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Werner-Wasik practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Werner-Wasik's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Werner-Wasik is licensed in Pennsylvania.

CMS data shows 494 Medicare services from Dr. Werner-Wasik across 12 procedure codes in 2024, for 106 Medicare patients. Medicare paid $43,947 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 106 Medicare patients who saw Dr. Werner-Wasik in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Werner-Wasik's median patient age at 74, with 56% women.

In 2018, Dr. Werner-Wasik wrote 12 Medicare Part D claims. They cover 1 drug, with $275 in total drug cost. In 2016, CMS named 13 claims across 1 drug.

Dmand AI links 95 papers to Dr. Werner-Wasik, published from 2007 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Radiosurgery. Dr. Werner-Wasik has published most often in Int J Radiat Oncol Biol Phys. Dr. Werner-Wasik's most frequent co-authors are David W. Andrews, MD, Adam P. Dicker, MD and James J. Evans, MD.

Dmand AI links Dr. Werner-Wasik to 10 clinical trials, 4 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Hematologic Neoplasms, Carcinoma, Lobular and Carcinoma, Non-Small-Cell Lung. Sidney Kimmel Cancer Center at Thomas Jefferson University sponsors the most, 8.

CMS Open Payments shows 46 general payments to Dr. Werner-Wasik from 9 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 48% of the total. Elekta, Inc. paid the most, $5,802. It also lists 1 research payment totaling $45 in 2016.